PALO ALTO, Calif.--(BUSINESS WIRE)--Compelling results from the first clinical study evaluating an innovative catheter-based treatment for chronic hypertension were presented today, as part of the Late Breaking Clinical Trials III: Emerging Technologies Session (Session No. 407) held at the 58th Annual Scientific Session of the American College of Cardiology in Orlando, Florida. These trial results, which evaluated the effects of renal denervation on hypertension, were published simultaneously in the medical journal, The Lancet, with an accompanying editorial noting the clinical importance of the technology and results.
